Derek Chalmers
2013
In 2013, Derek Chalmers earned a total compensation of $440K as President and Chief Executive Officer at Cara Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $40,000 |
|---|---|
| Salary | $400,000 |
| Total | $440,000 |
Chalmers received $400K in salary, accounting for 91% of the total pay in 2013.
Chalmers also received $40K in non-equity incentive plan.
Rankings
In 2013, Derek Chalmers' compensation ranked 9,770th out of 12,286 executives tracked by ExecPay. In other words, Chalmers earned more than 20.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,770 out of 12,286 | 21st |
Division Manufacturing | 3,625 out of 4,612 | 21st |
Major group Chemicals And Allied Products | 1,147 out of 1,462 | 22nd |
Industry group Drugs | 894 out of 1,156 | 23rd |
Industry Pharmaceutical Preparations | 699 out of 890 | 22nd |
Source: SEC filing on April 24, 2015.
Chalmers' colleagues
We found two more compensation records of executives who worked with Derek Chalmers at Cara Therapeutics in 2013.
News
Cara Therapeutics CEO Derek Chalmers' 2021 pay jumps 250% to $10M
April 22, 2022
Cara Therapeutics CEO Derek Chalmers' 2020 pay slips 15% to $2.9M
April 23, 2021
Cara Therapeutics CEO Derek Chalmers' 2019 pay jumps 23% to $3.4M
April 22, 2020
Cara Therapeutics Chief Medical Officer Joana Goncalves receives $3.7M in 2018
April 24, 2019